iCo Therapeutics (“iCo” or the “Company”) (TSX-V: ICO) (OTCQB: ICOTF), iCo Therapeutics, Inc. (“iCo”) and…
eabramovichJanuary 6, 2021
This year marks the 20th anniversary of the founding of Genome BC, the genomics research organization…
eabramovichDecember 17, 2020
Share prices of AbCellera Biologics Inc. (Nasdaq:ABCL) nearly tripled over the course of their first…
eabramovichDecember 16, 2020
Dr. Gail Murphy, Vice-President, Research & Innovation has announced Dr. Rachel Fernandez will be UBC’s…
eabramovichDecember 14, 2020
A Canadian biotechnology company has made history with the announcement of the BioNTech/Pfizer COVID-19 vaccine…
eabramovichDecember 11, 2020
Environmental Assessment (EA) is a critical step in evaluating the health of reclaimed mine sites.…
eabramovichDecember 10, 2020
One aspect of human existence we know to be universal is that we each have…
eabramovichDecember 9, 2020
Having already raised $105 million in a Series B in May, Canadian R&D engine AbCellera is gearing up for…
eabramovichDecember 8, 2020
With great pleasure we announce the appointment of our own Dr. Jim Johnson as the…
eabramovichDecember 7, 2020
